The high competition in cancer research is primarily due to the significant potential for [medical breakthroughs]() and the large market for effective cancer therapies. Cancer remains one of the leading causes of death worldwide, and any new treatment that can improve patient outcomes is highly valuable. Additionally, substantial funding from governments, private investors, and non-profit organizations further fuels this competitive landscape.
